LadRx Correlations
| LADXDelisted Stock | USD 2.37 0.14 6.28% |
The current 90-days correlation between LadRx and NovaBay Pharmaceuticals is -0.12 (i.e., Good diversification). The correlation of LadRx is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
LadRx Correlation With Market
Significant diversification
The correlation between LadRx and DJI is 0.02 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding LadRx and DJI in the same portfolio, assuming nothing else is changed.
LadRx |
The ability to find closely correlated positions to LadRx could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace LadRx when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back LadRx - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling LadRx to buy it.
Moving together with LadRx OTC Stock
| 0.65 | EMMA | Emmaus Life Sciences | PairCorr |
| 0.68 | IRD | Opus Genetics, Symbol Change | PairCorr |
| 0.83 | HRGN | Harvard Apparatus | PairCorr |
| 0.67 | HURA | TuHURA Biosciences Symbol Change | PairCorr |
| 0.81 | ZIVO | Zivo Bioscience | PairCorr |
| 0.81 | IMUX | Immunic | PairCorr |
| 0.78 | INTS | Intensity Therapeutics, | PairCorr |
Moving against LadRx OTC Stock
| 0.73 | FRTX | Fresh Tracks Therapeutics | PairCorr |
| 0.66 | VAXX | Vaxxinity | PairCorr |
| 0.62 | EPRX | Eupraxia Pharmaceuticals Upward Rally | PairCorr |
| 0.43 | EVLO | Evelo Biosciences | PairCorr |
| 0.74 | ZYME | Zymeworks Common Stock | PairCorr |
| 0.66 | ZVRA | Zevra Therapeutics | PairCorr |
| 0.56 | GRCE | Grace Therapeutics, Symbol Change | PairCorr |
| 0.74 | RVMDW | Revolution Medicines, | PairCorr |
| 0.67 | ITRM | Iterum Therapeutics PLC | PairCorr |
| 0.48 | ESLAW | Estrella Immunopharma | PairCorr |
| 0.35 | JSPR | Jasper Therapeutics | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between LadRx OTC Stock performing well and LadRx OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze LadRx's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| SGTX | 14.93 | 4.84 | 0.72 | 0.55 | 6.43 | 12.46 | 442.39 | |||
| NBY | 4.19 | 0.54 | 0.09 | (0.58) | 3.25 | 9.86 | 56.97 | |||
| INM | 5.08 | (0.76) | 0.00 | (2.79) | 0.00 | 9.93 | 39.14 | |||
| GOVX | 5.79 | (1.00) | 0.00 | (0.36) | 0.00 | 9.26 | 77.95 | |||
| PHIO | 4.67 | (0.20) | 0.00 | (0.10) | 0.00 | 11.78 | 36.22 | |||
| MTCR | 2.54 | 0.32 | 0.02 | (0.14) | 2.49 | 9.09 | 21.01 | |||
| MGTA | 2.62 | 0.06 | 0.00 | 0.26 | 3.40 | 5.88 | 16.99 | |||
| TARA | 3.37 | 0.65 | 0.17 | 3.43 | 2.78 | 8.67 | 19.48 | |||
| TCON | 6.84 | (1.55) | 0.00 | 0.72 | 0.00 | 19.59 | 52.05 | |||
| STSA | 3.39 | 0.41 | 0.09 | 0.62 | 3.54 | 5.71 | 70.12 |
View LadRx Related Equities
| Risk & Return | Correlation |
LadRx Corporate Management
Elected by the shareholders, the LadRx's board of directors comprises two types of representatives: LadRx inside directors who are chosen from within the company, and outside directors, selected externally and held independent of LadRx. The board's role is to monitor LadRx's management team and ensure that shareholders' interests are well served. LadRx's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, LadRx's outside directors are responsible for providing unbiased perspectives on the board's policies.
| John Caloz | Treasurer CFO | Profile | |
| Terri Stevens | Chief Officer | Profile | |
| Felix Kratz | Drug VP | Profile | |
| Cristina Newman | Co Sec | Profile | |
| Molly Poarch | Global Communications | Profile | |
| Molly Painter | Pres Operations | Profile | |
| Stephen Snowdy | Chief Officer | Profile |
Still Interested in LadRx?
Investing in delisted otcs can be risky, as the otc stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.